• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Chief Technology Officer Schroeder Jay

    5/20/25 6:11:28 PM ET
    $CNH
    Construction/Ag Equipment/Trucks
    Industrials
    Get the next $CNH alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Schroeder Jay

    (Last) (First) (Middle)
    C/O CNH INDUSTRIAL N.V.
    CRANES FARM ROAD, BASILDON

    (Street)
    ESSEX X0 SS14 3AD

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    CNH Industrial N.V. [ CNH ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Technology Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    05/16/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Share Units (1) 05/16/2025 A 20,407 (2) (2) Common Shares 20,407 $0 90,773(2)(3) D
    Explanation of Responses:
    1. Restricted share units ("RSUs") convert into common shares on a one-for-one basis.
    2. On May 16, 2025, the Reporting Person was granted 20,407 vesting on May 10, 2028.
    3. As previously reported, on May 10, 2023, the Reporting Person was granted 8,500 RSUs vesting on April 30, 2026; on May 10, 2024, the Reporting Person was granted 11,096 RSUs vesting on May 10, 2027; on November 15, 2024, the Reporting Person was granted 11,523 RSUs vesting on April 30, 2027; and on March 10, 2025, the Reporting Person was granted 39,247 RSUs vesting on May 10, 2027.
    /s/ Eric Mathison, attorney-in-fact 05/20/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CNH

    DatePrice TargetRatingAnalyst
    4/11/2025$18.00Market Perform → Outperform
    Northland Capital
    3/3/2025$16.00 → $15.00Outperform → Neutral
    Robert W. Baird
    1/28/2025$16.00Perform → Outperform
    Oppenheimer
    1/6/2025$17.00Mkt Perform → Outperform
    Bernstein
    12/17/2024$11.00 → $16.50Equal-Weight → Overweight
    Morgan Stanley
    11/11/2024$18.00Outperform → Market Perform
    Northland Capital
    9/24/2024$14.00Mkt Perform → Outperform
    Raymond James
    8/9/2024$11.00Market Perform
    BMO Capital Markets
    More analyst ratings